CCAP

CCAP

USD

Crescent Capital BDC Inc. Common stock

$14.570-0.360 (-2.411%)

Precio en Tiempo Real

Servicios financieros
Asset Management
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$14.930

Máximo

$14.950

Mínimo

$14.490

Volumen

0.25M

Fundamentos de la Empresa

Capitalización de Mercado

540.0M

Industria

Asset Management

País

United States

Estadísticas de Negociación

Volumen Promedio

0.18M

Bolsa

NGM

Moneda

USD

Rango de 52 Semanas

Mínimo $13.54Actual $14.570Máximo $20.19

Informe de Análisis de IA

Última actualización: 6 jun 2025
Generado por IAFuente de Datos: Yahoo Finance, Bloomberg, SEC

CCAP: Crescent Capital BDC Inc. Common Stock – Navigating Recent Shifts

Stock Symbol: CCAP Generate Date: 2025-06-06 16:58:47

Let's break down what's been happening with Crescent Capital BDC and what the data might be telling us.

Recent News Buzz

The news around CCAP lately has a pretty clear theme: analysts are getting a bit more cautious, and they're lowering their price targets. We saw Raymond James keep an "Outperform" rating but cut their target from $20 to $17. Then, Keefe, Bruyette & Woods actually downgraded the stock from "Outperform" to "Market Perform," also dropping their target to $17. Wells Fargo chimed in twice, first lowering their target from $18 to $16, and then again to $15, while maintaining an "Equal-Weight" rating.

What's driving this? Well, right in the middle of these analyst adjustments, Crescent Capital BDC reported its first-quarter 2025 earnings. They announced net investment income of $0.45 per share and net income of $0.11 per share, along with a second-quarter base dividend of $0.42 per share. While a dividend is generally good news, the analyst reactions suggest the overall earnings picture, or perhaps their outlook on the company's future, wasn't quite as strong as they'd hoped, leading to those lowered price expectations.

Price Check: What's the Stock Been Doing?

Looking at the last 30 days, CCAP's stock has seen some notable movement. Back in early March, it was trading around the $16.50 to $17.00 range, even touching above $17.30 in late March. However, we saw a significant dip around early April, with the price dropping sharply from the $16s down into the $14s and even touching $13.50 on April 9th. Since then, it's tried to recover, climbing back into the $15-$16 range through late April and early May.

More recently, particularly around the time of the earnings report and analyst downgrades (mid-May), the stock took another hit. On May 16th, it closed at $15.37, down from $16.61 just two days prior. Since then, it's mostly been trending downwards, with today's price sitting at $14.92. This recent slide aligns with the more cautious analyst sentiment.

The AI model from AIPredictStock.com gives us some interesting predictions for the very near term:

  • Today's Prediction: 0.00% change (meaning it expects the price to stay roughly where it is).
  • Next Day's Prediction: -0.51%
  • The Day after next day's Prediction: -3.67%

These predictions suggest continued downward pressure over the next couple of days, which fits with the recent price trend and the analyst adjustments.

Outlook & Ideas

Putting it all together, the current situation for CCAP seems to lean towards a cautious "hold" or even a "sell" for those looking to manage risk. The consistent lowering of price targets by multiple analysts, coupled with the recent downward trend in the stock price and the AI's prediction of further declines, paints a picture of potential near-term weakness.

The AI's recommendation data, while showing some bullish technical indicators like a MACD Golden Cross and strong buying pressure (high OBV), also highlights fundamental concerns like negative revenue growth and high debt. The "AI Prediction" reason specifically notes "downward pressure with support level around $0.97," which seems like a typo and likely refers to a much higher support level, but the sentiment of downward pressure is clear. The overall "recommend_score" is 53.07, with "Bullish Momentum" tags, but the price change direction is indicated as -1 (downward). This mixed signal suggests conflicting forces at play, but the recent news and price action are hard to ignore.

Potential Entry Consideration: Given the current downward trend and analyst caution, this might not be the ideal time for new entries unless you're a very short-term trader looking for a bounce off a strong support level. The recommendation data points to potential entry points around $14.65 or $14.72, which are very close to the current price. If the stock dips to these levels and shows signs of stabilizing, it might be a point for a very speculative, short-term entry, but the overall trend is concerning.

Potential Exit/Stop-Loss Consideration: For those holding the stock, a stop-loss around $14.09, as suggested by the recommendation data, seems prudent. This level is below recent lows and could help limit further losses if the downward trend accelerates. For taking profits, the recommendation suggests $15.03, which is just above the current price. This implies that any short-term bounce might be limited, aligning with the cautious outlook.

Company Context

Crescent Capital BDC Inc. operates in the Asset Management sector, specializing in direct investments in middle-market companies. As a business development company (BDC), its performance is often tied to the health of the private credit markets and the companies it lends to. The reported net investment income and dividend are key metrics for BDCs, but the analyst reactions suggest underlying concerns about the portfolio or future earnings potential. The company's P/E ratio of 7.38 is relatively low, but this needs to be viewed in context of its industry and the noted negative revenue growth. Its market cap is around $553 million, making it a smaller player, which can sometimes lead to more volatile price swings.


Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Investing in stocks involves risks, and past performance is not indicative of future results. Always conduct your own thorough research and consult with a qualified financial professional before making any investment decisions.

Noticias Relacionadas

Analyst Upgrades

Raymond James Maintains Outperform on Crescent Capital BDC, Lowers Price Target to $17

Raymond James analyst Robert Dodd maintains Crescent Capital BDC with a Outperform and lowers the price target from $20 to $17.

Ver más
Raymond James Maintains Outperform on Crescent Capital BDC, Lowers Price Target to $17
Analyst Upgrades

Keefe, Bruyette & Woods Downgrades Crescent Capital BDC to Market Perform, Lowers Price Target to $17

Keefe, Bruyette & Woods analyst Ryan Lynch downgrades Crescent Capital BDC from Outperform to Market Perform and lowers the price target from $18.5 to $17.

Ver más
Keefe, Bruyette & Woods Downgrades Crescent Capital BDC to Market Perform, Lowers Price Target to $17
Analyst Upgrades

Wells Fargo Maintains Equal-Weight on Crescent Capital BDC, Lowers Price Target to $15

Wells Fargo analyst Finian O'Shea maintains Crescent Capital BDC with a Equal-Weight and lowers the price target from $16 to $15.

Ver más
Wells Fargo Maintains Equal-Weight on Crescent Capital BDC, Lowers Price Target to $15
GlobeNewswire

Crescent Capital BDC, Inc. Reports First Quarter 2025 Earnings Results; Declares a Second Quarter Base Dividend of $0.42 Per Share

LOS ANGELES, May 14, 2025 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. ("Crescent BDC" or "Company") (NASDAQ:CCAP) today reported net investment income of $0.45 per share and net income of $0.11 per share, for the

Ver más
Crescent Capital BDC, Inc. Reports First Quarter 2025 Earnings Results; Declares a Second Quarter Base Dividend of $0.42 Per Share
Analyst Upgrades

Wells Fargo Maintains Equal-Weight on Crescent Capital BDC, Lowers Price Target to $16

Wells Fargo analyst Finian O'Shea maintains Crescent Capital BDC with a Equal-Weight and lowers the price target from $18 to $16.

Ver más
Wells Fargo Maintains Equal-Weight on Crescent Capital BDC, Lowers Price Target to $16

Predicción de IABeta

Recomendación de IA

Bajista

Actualizado el: 12 jun 2025, 12:16

BajistaNeutralAlcista

56.6% Confianza

Riesgo y Negociación

Nivel de Riesgo3/5
Riesgo Medio
Adecuado Para
Valor
Guía de Negociación

Punto de Entrada

$14.55

Toma de Ganancias

$14.85

Stop Loss

$13.96

Factores Clave

El DMI muestra una tendencia bajista (ADX:13.9, +DI:6.5, -DI:8.6), lo que sugiere precaución
El precio actual está extremadamente cerca del nivel de soporte ($14.59), lo que sugiere una fuerte oportunidad de compra
El volumen de operaciones es 12.9 veces el promedio (2,783), lo que indica una presión de compra extremadamente fuerte
MACD -0.0073 is below signal line -0.0073, indicating a bearish crossover

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.